Vasamed, Inc. (VSMD)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2005 | 4.74 Million USD | -24.66% |
| 2004 | 6.29 Million USD | 175.24% |
| 2003 | 2.28 Million USD | 21.5% |
| 2002 | 1.88 Million USD | -31.02% |
| 2001 | 2.72 Million USD | -26.38% |
| 2000 | 3.7 Million USD | -52.96% |
| 1999 | 7.87 Million USD | -36.46% |
| 1998 | 12.4 Million USD | -1.59% |
| 1997 | 12.6 Million USD | 15.6% |
| 1996 | 10.9 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2006 Q1 | 1.18 Million USD | 22.3% |
| 2006 Q2 | 1.23 Million USD | 4.37% |
| 2006 Q3 | 1.23 Million USD | -0.18% |
| 2005 Q2 | 1.23 Million USD | 29.91% |
| 2005 Q4 | 969.34 Thousand USD | -38.85% |
| 2005 Q1 | 951.59 Thousand USD | 6.79% |
| 2005 FY | 4.74 Million USD | -24.66% |
| 2005 Q3 | 1.58 Million USD | 28.23% |
| 2004 Q4 | 891.12 Thousand USD | -36.9% |
| 2004 Q1 | 1.03 Million USD | 65.82% |
| 2004 FY | 6.29 Million USD | 175.24% |
| 2004 Q3 | 1.41 Million USD | -52.26% |
| 2004 Q2 | 2.95 Million USD | 186.16% |
| 2003 FY | 2.28 Million USD | 21.5% |
| 2003 Q1 | 18 Thousand USD | -91.7% |
| 2003 Q4 | 623.36 Thousand USD | -28.86% |
| 2003 Q3 | 876.19 Thousand USD | 13.87% |
| 2003 Q2 | 769.47 Thousand USD | 4173.9% |
| 2002 Q4 | 217.02 Thousand USD | -69.01% |
| 2002 Q2 | 239 Thousand USD | -49.75% |
| 2002 FY | 1.88 Million USD | -31.02% |
| 2002 Q3 | 700.25 Thousand USD | 192.98% |
| 2002 Q1 | 475.66 Thousand USD | -7.96% |
| 2001 Q3 | 786.74 Thousand USD | 28.99% |
| 2001 FY | 2.72 Million USD | -26.38% |
| 2001 Q1 | 815.21 Thousand USD | 30.42% |
| 2001 Q2 | 609.92 Thousand USD | -25.18% |
| 2001 Q4 | 516.81 Thousand USD | -34.31% |
| 2000 FY | 3.7 Million USD | -52.96% |
| 2000 Q4 | 625.07 Thousand USD | -34.16% |
| 2000 Q3 | 949.41 Thousand USD | -7.0% |
| 2000 Q2 | 1.02 Million USD | -8.13% |
| 2000 Q1 | 1.11 Million USD | -29.63% |
| 1999 Q4 | 1.57 Million USD | 5.27% |
| 1999 Q2 | 1.5 Million USD | -50.0% |
| 1999 Q3 | 1.5 Million USD | 0.0% |
| 1999 Q1 | 3 Million USD | 0.0% |
| 1999 FY | 7.87 Million USD | -36.46% |
| 1998 Q1 | 2.9 Million USD | 11.54% |
| 1998 FY | 12.4 Million USD | -1.59% |
| 1998 Q4 | 3 Million USD | -9.09% |
| 1998 Q3 | 3.3 Million USD | 0.0% |
| 1998 Q2 | 3.3 Million USD | 13.79% |
| 1997 Q4 | 2.6 Million USD | -21.21% |
| 1997 FY | 12.6 Million USD | 15.6% |
| 1997 Q1 | 3.3 Million USD | 17.86% |
| 1997 Q2 | 3.5 Million USD | 6.06% |
| 1997 Q3 | 3.3 Million USD | -5.71% |
| 1996 Q3 | 2.7 Million USD | -10.0% |
| 1996 Q2 | 3 Million USD | 36.36% |
| 1996 Q4 | 2.8 Million USD | 3.7% |
| 1996 FY | 10.9 Million USD | 0.0% |
| 1996 Q1 | 2.2 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.16 Million USD | -307.337% |
| Ansell Limited | 129.3 Million USD | 96.332% |
| Ansell Limited | 129.3 Million USD | 96.332% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 31.13 Million USD | 84.77% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -1.59 Million USD | 397.192% |
| Psykey, Inc. | -797.5 Thousand USD | 694.643% |
| ConvaTec Group Plc | 262.7 Million USD | 98.195% |
| ConvaTec Group Plc | 262.7 Million USD | 98.195% |
| Encision Inc. | -640.78 Thousand USD | 840.079% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 3444.124% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | 4413.929% |
| Innovative MedTech Inc. | -4.27 Million USD | 210.955% |
| LifePoint, Inc. | -7.49 Million USD | 163.271% |
| Medite Cancer Diagnostics, Inc. | -6.48 Million USD | 173.184% |
| Paradigm Medical Industries, Inc. | 330 Thousand USD | -1337.061% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -122.89 Thousand USD | 3958.981% |
| Reflect Scientific, Inc. | -467.27 Thousand USD | 1114.878% |
| SmileDirectClub, Inc. | -241.15 Million USD | 101.966% |
| Sector 10, Inc. | -39.84 Thousand USD | 12002.173% |
| Shandong Weigao Group Medical Polymer Company Limited | 319.6 Million USD | 98.516% |
| SheerVision, Inc. | 155.72 Thousand USD | -2945.286% |
| United Health Products, Inc. | -2.42 Million USD | 295.435% |
| Wearable Health Solutions, Inc. | -2.29 Million USD | 306.714% |
| Yubo International Biotech Limited | -1.2 Million USD | 493.479% |